Collecting Cancer Data: Lung

Similar documents
Lung 8/7/14. Collecting Cancer Data: Lung NAACCR Webinar Series. August 7, 2014

Collaborative Stage. Site-Specific Instructions - LUNG

NAACCR Webinar Series 1

Lung /1/16. Please submit all questions concerning webinar content through the Q&A panel. Reminder:

Lung /4/18. Please submit all questions concerning the webinar content through the Q&A panel.

AJCC-NCRA Education Needs Assessment Results

Molly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010

Case Scenario 1. The patient agreed to a CT guided biopsy of the left upper lobe mass. This was performed and confirmed non-small cell carcinoma.

Bronchogenic Carcinoma

Lung. 10/24/13 Chest X-ray: 2.9 cm mass like density in the inferior lingular segment worrisome for neoplasm. Malignancy cannot be excluded.

Slide 1. Slide 2. Slide 3. Investigation and management of lung cancer Robert Rintoul. Epidemiology. Risk factors/aetiology

North of Scotland Cancer Network Clinical Management Guideline for Non Small Cell Lung Cancer

Mediastinal Staging. Samer Kanaan, M.D.

Q&A. Fabulous Prizes. Collecting Cancer Data: Bladder, Renal Pelvis, and Ureter 5/2/13. NAACCR Webinar Series

An Update: Lung Cancer

FDG PET/CT in Lung Cancer Read with the experts. Homer A. Macapinlac, M.D.

Thyroid and Adrenal Gland

Lung Cancer Imaging. Terence Z. Wong, MD,PhD. Department of Radiology Duke University Medical Center Durham, NC 9/9/09

NAACCR Webinar Series 1

Role of Surgery in Management of Non Small Cell Lung Cancer. Dr. Ahmed Bamousa Consultant thoracic surgery Prince Sultan Military Medical City

B REAST STAGING FORM. PATHOLOGIC Extent of disease through completion of definitive surgery. CLINICAL Extent of disease before any treatment

Case Scenario 1. Pathology report Specimen from mediastinoscopy Final Diagnosis : Metastatic small cell carcinoma with residual lymphatic tissue

The 8th Edition Lung Cancer Stage Classification

B REAST STAGING FORM. PATHOLOGIC Extent of disease through completion of definitive surgery. CLINICAL Extent of disease before any treatment

WHITE PAPER - SRS for Non Small Cell Lung Cancer

GUIDELINES FOR CANCER IMAGING Lung Cancer

EVERYTHING YOU WANTED TO KNOW ABOUT. Robin Billet, MA, CTR, Head & Neck CTAP Member May 9, 2013

ACRIN NLST 6654 Primary Lung Cancer. F1/F2 Interval: to (mm-dd-yyyy) 1. Date of diagnosis: (mm-dd-yyyy)

Seventh Edition of the Cancer Staging Manual and Stage Grouping of Lung Cancer. Quick Reference Chart and Diagrams

The International Association for the Study of Lung Cancer (IASLC) Lung Cancer Staging Project, Data Elements

COLLECTING CANCER DATA: STOMACH AND ESOPHAGUS

Q&A. Overview. Collecting Cancer Data: Prostate. Collecting Cancer Data: Prostate 5/5/2011. NAACCR Webinar Series 1

Case Scenario year-old white male presented to personal physician with dyspepsia with reflux.

Exercise 15: CSv2 Data Item Coding Instructions ANSWERS

Charles Mulligan, MD, FACS, FCCP 26 March 2015

Educational Objectives. Managing Lung Cancer From the Solitary Pulmonary Nodule to Complex Cases: A Multidisciplinary Approach.

2010 Update. NAACCR Webinar Series 1 4/1/2010. Agenda. Access to 2010 Information. CSv2. Collecting Cancer Data: Soft Tissue Sarcoma

Adam J. Hansen, MD UHC Thoracic Surgery

LUNG STAGING FORM LATERALITY: LEFT RIGHT BILATERAL

Collecting Cancer Data: Pancreas

Respiratory Interactive Session. Elaine Borg

Testicular Malignancies /8/15

Q&A Session NAACCR Webinar Series Collecting Cancer Data: Pancreas January 05, 2012

PLACE LABEL HERE. Radiation Therapy Oncology Group Phase II - SBRT - Medically Inoperable I /II NSCLC Follow-up Form. RTOG Study No.

Summary Stage 2018 (SS2018)

Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules

2018 Implementation: SEER Summary Stage 2018

Lecturer: Ms DS Pillay ROOM 2P24 25 February 2013

THORACIC MALIGNANCIES

Lung Cancer - Suspected

Case Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery.

Larry Tan, MD Thoracic Surgery, HSC. Community Cancer Care Educational Conference October 27, 2017

9/17/2013. Presentation Outline. Overview

FCDS 2013 Educational Webcast Series September 19, Mayra Espino, BA, RHIT, CTR Steven Peace, BS, CTR FCDS QC Staff

Radiological staging of lung cancer. Shukri Loutfi,MD,FRCR Consultant Thoracic Radiologist KAMC-Riyadh

QUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX

Chief Complain. For chemotherapy

Case Scenario. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.

Multiple Primary Quiz

Do you want to be an excellent Radiologist? - Focus on the thoracic aorta on lateral chest image!!!

OBJECTIVES. Solitary Solid Spiculated Nodule. What would you do next? Case Based Discussion: State of the Art Management of Lung Nodules.

QUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX

Collecting Cancer Data: Breast. Prizes! Collecting Cancer Data: Breast 8/4/ NAACCR Webinar Series 1. NAACCR Webinar Series

Case Conference: Post-Operative Radiotherapy for Non-Small Cell Lung Cancer. Doug Rahn 6/1/12

Chest X-ray Interpretation

Case Scenario 1. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.

GROUP 1: Peripheral tumour with normal hilar and mediastinum on staging CT with no disant metastases. Including: Excluding:

Surgical management of lung cancer

Esophagus Stomach 4/2/15

Histopathology of NSCLC, IHC markers and ptnm classification

Pancreas Quizzes c. Both A and B a. Directly into the blood stream (not using ducts)

Q&A. Fabulous Prizes. Collecting Cancer Data: Bone and Soft Tissue 1/10/113. NAACCR Webinar Series

8. The polyp in the illustration can be described as (circle all that apply) a. Exophytic b. Pedunculated c. Sessile d. Frank

Guidelines for Assigning Summary Stage 2000

NAACCR Webinar Series 1

Pancreas Case Scenario #1

Special Treatment Issues in Non-small Cell Lung Cancer

OSCaR UPDATE. Manager s Update Donald Shipley, MS. Oregon State Cancer Registry

6 th Reprint Handbook Pages AJCC 7 th Edition

Video-Mediastinoscopy Thoracoscopy (VATS)

Thursday, August 16, :30 AM - 4:30 PM and Friday, August 17, :30 AM 12:00 PM Crowne Plaza 830 Phillips Lane Louisville, KY 40209

Radiology Pathology Conference

Abstracting and Coding Boot Camp: Cancer Case Scenarios

Small Cell Lung Cancer Early Detection, Diagnosis, and Staging

Case Scenario 1. Pathology: Specimen type: Incisional biopsy of the glottis Histology: Moderately differentiated squamous cell carcinoma

Quiz. b. 4 High grade c. 9 Unknown

Imaging of Lung Cancer: A Review of the 8 th TNM Staging System

SEER Summary Stage Still Here!

Karoline Nowillo, MD. February 1, 2008

FDG PET/CT STAGING OF LUNG CANCER. Dr Shakher Ramdave

NAACCR Webinar Series 1

Boot Camp Case Scenarios

LUNG CANCER. Agnieszka Słowik, MD. Department of Oncology, University Hospital in Cracow Jagiellonian University

Liver 6/5/14. Collecting Cancer Data: Liver NAACCR Webinar Series. June 5, 2014

MCR: MANAGEMENT OF 2018 CHANGES. By: Maricarmen Traverso-Ortiz MPH, CGG, CTR

Thoracic Surgery; An Overview

Case Scenario #1 Larynx

Non small cell Lung Cancer

Lung Cancer Very common Very lethal Median age of diagnosis i approximately 70 years, but affects all ages In the United States, the highest incidence

Early-stage locally advanced non-small cell lung cancer (NSCLC) Clinical Case Discussion

Transcription:

Collecting Cancer Data: Lung NAACCR 2011 2012 Webinar Series 2/2/2012 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar at your site, please collect their names and emails. We will be distributing a Q&A document in about one week. This document will fully answer questions asked during the webinar and will contain any corrections that we may discover after the webinar. 2 Fabulous Prizes NAACCR 2011 2012 Webinar Series 1

Agenda Coding Moment CS Mets at DX Metastatic Sites Overview Anatomy MP/H Treatment Quiz 1 Collaborative Stage Data Collection System Quiz 2 Review of Case Scenarios 4 CS Mets at DX Metastatic Sites CODING MOMENT CS Mets at DX Metastatic Sites Four CS Mets at DX Metastatic Sites Data Items Identify whether or not primary has metastasized to a specific site Provides information on specific metastatic sites for data analysis NAACCR 2011 2012 Webinar Series 2

CS Mets at DX Metastatic Sites Code 0 No distant metastasis at all CS Mets at DX = 00 No distant metastasis to the specific site Code 1 Distant metastasis to the specific site Code 8 Not applicable for the site Code 9 Cannot be determined from the record if patient has metastasis to the specific site CS Mets at DX = 99 CS Mets at DX Bone Patient complained of left leg pain. Bone scan showed metastasis to left femur and sacrum. CT scan showed large left lung mass invading left pleura. Biopsy positive for squamous cell carcinoma; primary lung cancer. What is the code for CS Mets at DX Bone? 0: None; no bone metastasis 1: Yes 8: Not applicable 9: unknown CS Mets at DX Brain Intracranial swelling confined to cerbral meninges. Biopsy of cerebral meninges positive for adenocarcinoma. Large left lung upper lobe mass, malignant, per CT of chest. Final diagnosis is lung cancer. What is the code for CS Mets at DX Brain? 0: None; no brain metastasis 1: Yes 8: Not applicable 9: unknown NAACCR 2011 2012 Webinar Series 3

CS Mets at DX Liver Biopsy of left lower lung lobe confirms adenocarcinoma. CT scan of abdomen shows abdominal carcinomatosis. What is the code for CS Mets at DX Liver? 0: None; no liver metastasis 1: Yes 8: Not applicable 9: unknown CS Mets at DX Lung CT scan of chest: 3 cm left upper lung lobe mass and 2 cm left lower lobe mass, both malignant and confined to left lung. No masses in right lung. This is a single primary. What is the code for CS Mets at DX Lung? 0: None; no lung metastasis 1: Yes 8: Not applicable 9: unknown LUNG NAACCR 2011 2012 Webinar Series 4

The Numbers Estimated new cases and deaths from lung cancer (non small cell and small cell combined) in the United States in 2012: New cases: 226,160 Deaths: 160,340 American Cancer Society Estimated new cases and deaths in Canada 2011: New cases: 25,300 Deaths: 20,600 Canadian Cancer Society C34.1 C34.2 C34.3 C33.9 C34.0 C34.1 C34.3 Respiratory Anatomy 2006 Terese Winslow, U.S. Govt. has certain rights Respiratory Anatomy 2006 Terese Winslow, U.S. Govt. has certain rights NAACCR 2011 2012 Webinar Series 5

Lung Cancer Stage 3B (Part 1) 2010 Terese Winslow, U.S. Govt. has certain rights 1 Oblique Fissure 7 Apex (C34.1) 2 Lower Lobe Lung 3 Hilum 4 Cardiac Notch 6 Lingula (C34.1) 5 Diaphragmatic Surface C34.0 Carina Hilum Hilum Main Stem Bronchus Respiratory Anatomy 2006 Terese Winslow, U.S. Govt. has certain rights NAACCR 2011 2012 Webinar Series 6

Pancoast Tumor Form in the extreme apex of the lung in the superior sulcus Tend to involve the chest wall structures rather than the underlying lung tissue Pancoast syndrome is characterized by pain in the shoulder and along the inner side of the arm or hand Lung Cancer Stage 3B (Part 1) 2010 Terese Winslow, U.S. Govt. has certain rights Brachial Nerve Bundle Pancoast Tumor Question If the term "Pancoast tumor, NOS" is considered malignant by definition, should the date of diagnosis be coded to the date of the clinical diagnosis when the clinical diagnosis is made prior to the histologic confirmation of the malignancy? NAACCR 2011 2012 Webinar Series 7

Answer Yes, Pancoast tumor is by definition malignant. It is defined as a lung cancer in the uppermost segment of the lung that directly invades into the brachial plexus (nerve bundles) of the neck, causing pain. If a Pancoast tumor was identified on imaging prior to the biopsy, the date of diagnosis should be linked to the Pancoast tumor report. Vocal Cord Paralysis or Superior Vena Cava Syndrome Vocal cord paralysis May be caused by involvment of the recurrent branch of the vagus nerve Superior vena cava obstruction or compression of the trachea or esophagus May be caused by direct extension from the primary tumor Lung Cancer Stage 3B (Part 1) 2010 Terese Winslow, U.S. Govt. has certain rights Vagus Nerve Primary Tumor NAACCR 2011 2012 Webinar Series 8

Superior Vena Blood Cava Supply Inferior Vena Cava Aorta Thoracic Cavity Atelectasis The collapse of part or (much less commonly) all of a lung Caused by a blockage of the air passages (bronchus or bronchioles) or by pressure on the outside of the lung. Respiratory Anatomy 2006 Terese Winslow, U.S. Govt. has certain rights NAACCR 2011 2012 Webinar Series 9

Obstructive Pneumonitis Combination of atelectasis, bronchiectasis with mucous plugging, and parenchymal inflammation that develops distal to an obstructing endobronchial lesion. Respiratory Anatomy 2006 Terese Winslow, U.S. Govt. has certain rights Pleural Effusion Caused by excess fluid accumulation between the two layers of the pleura Consider malignant unless multiple cytopathologic examinations of pleural and/or pericardial fluid are negative for tumor, and the fluid is nonbloody and is not an exudates Direct Extension from Lung to the Pleura Layer of the pleura Lung parenchyma Connective tissue Elastic fibers Submesothelial tissue (PL1) Mesothelial cells on basement membrane (PL2) Pleural space Parietal pleura (PL3) Lung Cancer Stage 3B (Part 1) 2010 Terese Winslow, U.S. Govt. has certain rights Visceral Pleura Parietal Pleura NAACCR 2011 2012 Webinar Series 10

Pleural Tumor Foci or Nodules Pleural tumor foci or nodule separate from direct invasion Lung Cancer Stage 3B (Part 1) Visceral 2010 Terese Winslow, U.S. Govt. has certain rights Pleura Parietal Pleura Question How is the term "pleural based mass" interpreted in CS Extension? Answer When you have a description of "pleural based mass", this is stating that the mass is confined to the lung. A "pleura based mass" does not mean involvement of the pleura (do not code SSF2, Visceral Pleural Invasion, as positive based on this description). If the pleural based mass has a histology that is common to the lung, the code would be lung. For example, pleural based mass with a histology of adenocarcinoma. The only exception to this would be if your histology is Mesothelioma (9050 9053). In that case, your primary site code would be for Pleura, C38.4. NAACCR 2011 2012 Webinar Series 11

Pop Quiz Patient has a single pleural based mass located in the right lung. A biopsy confirms this is adenocarcinoma. What is the primary site? Patient has a right upper lobe primary tumor with multiple pleural based nodules at the right lung base suspicious for metastasis. Where are these pleural based nodules located? Regional Lymph Nodes Hilar lymph nodes Present around the main stem bronchi Lobar Located around a lobar bronchus Interlobar Located between the lobes of the lung Segmental Located along a segmental bronchus Sub segmental Located along the sub segmental bronchus and/or the peripheral bronchus. Regional Lymph Nodes Superior mediastinal Aortic Pulmonary Inferior mediastinal Image Source: SEER Training Website NAACCR 2011 2012 Webinar Series 12

Regional Lymph Nodes Aortic Carinal Mediastinal Peri/paratracheal Scalene Supraclavicular Respiratory Anatomy 2006 Terese Winslow, U.S. Govt. has certain rights Question What would I assign as the topography code in the following situation? Chest CT shows 1.6 cm RUL suspicious mass and too numerous to count nodules throughout both lungs. Core biopsy of mass in the RUL compatible with adenocarcinoma. NAACCR 2011 2012 Webinar Series 13

Answer For lung primaries with one large mass and numerous nodules, code the primary site to the subsite where the large mass is located. Primary site is C34.1 MPH Rules NAACCR 2011 2012 Webinar Series 14

Histologies Squamous cell carcinoma More common among men than women Strongly associated with smoking Often arises in the larger bronchi Often TTF 1 negative Adenocarcinoma Most common histologic subtype in US and Canada Often arises in the terminal bronchioles Mixtures of adenocarcinoma histologic subtypes are more common than tumors consisting purely of a single pattern of acinar, papillary, bronchioloalveolar, and solid adenocarcinoma with mucin formation. Usually TTF 1 positive Histologies Large cell carcinoma May be undifferentiated squamous cell or adenocarcinomas Large cell neuroendocrine carcinoma High grade non small cell carcinoma. Very poor prognosis similar to small cell carcinoma Small cell carcinoma Account for about 15% of bronchogenic carcinomas Aggressive disease More responsive to chemotherapy and radiation than non small cell carcinomas Multiple Primary Rules Unknown if single or multiple tumors Rule M1 When it is not possible to determine if there is a single tumor or multiple tumors, opt for a single tumor and abstract as a single primary. Single Tumor Rule M2 A single tumor is always a single primary. NAACCR 2011 2012 Webinar Series 15

Multiple Tumors Rule M3 Tumors in sites with ICD O 3 topography codes that are different at the second (Cxxx) and/or third character (Cxxx) are multiple primaries. Rule M4 At least one tumor that is non small cell carcinoma (8046) and another tumor that is small cell carcinoma (8041 8045) are multiple primaries. Multiple Tumors Rule M5 A tumor that is adenocarcinoma with mixed subtypes (8255) and another that is bronchioloalveolar (8250 8254) are multiple primaries Rule M6 A single tumor in each lung is multiple primaries Rule M7 Multiple tumors in both lungs with ICD O 3 histology codes that are different at the first (xxxx), second (xxxx) or third (xxxx) number are multiple primaries Multiple Tumors Rule M8 Tumors diagnosed more than three (3) years apart are multiple primaries Rule M9 An invasive tumor following an in situ tumor more than 60 days after diagnosis is a multiple primary Rule M10 Tumors with non small cell carcinoma, NOS (8046) and a more specific non small cell carcinoma type (Chart 1) are a single primary NAACCR 2011 2012 Webinar Series 16

Multiple Tumors Rule M11 Tumors with ICD O 3 histology codes that are different at the first (xxxx), second (xxxx) or third (xxxx) number are multiple primaries Rule M12 Tumors that do not meet any of the above criteria are a single primary Single Tumor Histology Rules Rule H1 Code the histology documented by the physician when there is no pathology/cytology specimen or the pathology/cytology report is not available Rule H2 Code the histology from a metastatic site when there is no pathology/cytology specimen from the primary site Rule H3 Code the histology when only one histologic type is identified Single Tumor Histology Rules Rule H4 Code the invasive histologic type when a single tumor has invasive and in situ components Rule H5 Code the most specific term using Chart 1 when there are multiple histologies within the same branch Rule H6 Code the appropriate combination/mixed code (Table 1) when there are multiple specific histologies or when there is a nonspecific with multiple specific histologies Rule H7 Code the histology with the numerically higher ICD O 3 code NAACCR 2011 2012 Webinar Series 17

Multiple Tumor Histology Rules Rule H8 Code the histology documented by the physician when there is no pathology/cytology specimen or the pathology/cytology report is not available Rule H9 Code the histology from a metastatic site when there is no pathology/cytology specimen from the primary site. Rule H10 Code the histology when only one histologic type is identified Multiple Tumor Histology Rules Rule H11 Code the histology of the most invasive tumor Rule H12 Code the most specific term using Chart 1 when there are multiple histologies within the same branch Rule H13 Code the histology with the numerically higher ICD O 3 code Lung Cancer Work up Imaging studies Chest x ray CT scan or MRI of lung CT scan or MRI Bone Brain Liver/spleen Esophagus PET or PET/CT scans NAACCR 2011 2012 Webinar Series 18

Lung Cancer Work up Endoscopy Bronchoscopy Thoroscopy Mediastinoscopy Laryngoscopy Esophagoscopy Endoscopic ultrasound EUS FNA EBUS Treatment NSCLC Surgery Wedge resection (21) Segmental resection (22) Sleeve Lobectomy Lobectomy (30) Pneumonectomy (50) Respiratory Anatomy 2006 Terese Winslow, U.S. Govt. has certain rights Radiation Stereotactic Ablative Radiation (SABR) AKA Stereotactic Body Radiation (SBRT) Code 41 IMRT Code 31 3D Conformal Code 32 6 10 MV photons Code 24 57 NAACCR 2011 2012 Webinar Series 19

Chemotherapy Cisplatin and Vinorelbine or Etoposide or Gemcitabine or Docetaxel 58 Treatment Non Small Cell Carcinoma Stage I, Stage IIA, and Stage IIB (T1 2, N1) Disease Surgery Observation Chemotherapy Radiation 59 Treatment Non Small Cell Carcinoma Stage IIB (T3, N0), Stage IIIA, and Stage IIIB Disease Neoadjuvant chemo/radiation Resection Chemotherapy Concurrent chemoradiation Radiation 60 NAACCR 2011 2012 Webinar Series 20

Treatment Non Small Cell Carcinoma Stage IV Chemotherapy Radiation 61 Treatment Small Cell Carcinoma Surgery (early stage disease only) Chemotherapy Radiation 62 Questions? QUIZ 1 63 NAACCR 2011 2012 Webinar Series 21

Lung COLLABORATIVE STAGE DATA COLLECTION SYSTEM CS Tumor Size: Lung Do not code size of hilar mass unless it is the primary lung tumor Site specific special codes 996: Malignant cells present in bronchopulmonary secretions, but no tumor seen radiographically or during bronchoscopy; "occult" carcinoma 997: Diffuse (entire lobe) 998: Diffuse (entire lung or NOS) CS Extension: Lung Tumor involves main stem bronchus Code 200: 2 cm or more from carina OR distance from carina unknown and patient had lobectomy, segmental resection, or wedge resection Code 210: Distance from carina not stated and no lobectomy, segmental resection, or wedge resection Code 500: Less than 2.0 cm from carina NAACCR 2011 2012 Webinar Series 22

CS Extension: Lung Bronchopneumonia is NOT obstructive pneumonitis Code 400: Atelectasis/obstructive pneumonitis extends to hilar region but does not involve entire lung OR NOS Code 550: Atelectasis/obstructive pneumonitis involving entire lung CS Extension: Lung Visceral pleural invasion 410: Extension to but not into pleura, including invasion of elastic layer BUT not through the elastic layer 420: Invasion of pleura, including invasion through the elastic layer 430: Invasion of pleura, NOS Additional information collected in SSF2 Parietal pleural invasion Code 600 CS Extension: Lung Vocal cord paralysis Code 700 UNLESS the tumor is peripheral and unrelated to vocal cord paralysis Then code in CS Lymph Nodes Involvement of the pulmonary artery or vein Code 700 UNLESS involvement is only in the lung, not mediastinum NAACCR 2011 2012 Webinar Series 23

CS Extension: Lung Do not code separate lung tumor nodules in CS Extension Code presence or absence of separate nodules in ipsilateral lung in SSF1 Code presence of separate metastatic nodules in contralateral lung in CS Mets at DX Do not code the presence of pleural or pericardial effusion in CS Extension Code in CS Mets at DX CS Extension: Lung Multiple CS data items used to map stage for lung CS Extension codes 000 440, 455 520, 540 600, 730, and 950 999 AJCC 7th Ed. T category based on the values of CS Tumor Size, CS Extension, and CS SSF1 CS Extension codes 000, 950, 980 and 999 Summary Stage 77 based on the values of CS Extension and Site Specific Factor # 1 CS Extension codes 000 700, 740, 950 999 Summary Stage 2000 based on the values of CS Extension and Site Specific Factor #1 Pop Quiz Left upper lung lobectomy: 4 cm and 1 cm tumors in left upper lobe; both adenocarcinoma with no extension. Per MP/H rules this is a single primary What is the code for CS Tumor Size? 010 040 050 999 What is the code for CS Extension? 100: Tumor confined to 1 lung 300: Localized NOS 455: Stated as T2a 570: Stated as T3 NAACCR 2011 2012 Webinar Series 24

CS Lymph Nodes: Lung Description of mass, adenopathy, or enlargement of lymph nodes listed in codes 100 or 200 Code as involvement in CS Lymph Nodes Documentation of no evidence of spread or remaining examination negative Code as no involvement in CS Lymph Nodes CS Lymph Nodes: Lung Vocal cord paralysis Code 200 if primary tumor is peripheral and clearly unrelated to vocal cord paralysis, SVC obstruction, or compression of the trachea or the esophagus Otherwise code in CS Extension Pop Quiz CT scan of chest: Right upper lobe tumor, probably malignant, 4 cm. Right and left hilar lymphadenopathy and right mediastinal lymphadenopathy. What is the code for CS Lymph Nodes? 100: Ipsilateral hilar nodes 200: Ipsilateral mediastinal nodes 600: Contralateral/bilateral hilar nodes; contralateral/bilateral mediastinal nodes 999: Unknown NAACCR 2011 2012 Webinar Series 25

CS Mets at DX: Lung Consider pleural or pericardial effusion as malignant UNLESS Multiple cytopathologic exams of effusion are negative It is documented that effusion is not related to tumor Code ipsilateral or contralateral malignant pleural effusion in CS Mets at DX Codes 15 18 Code malignant pericardial effusion in CS Mets at DX Code 20 CS Mets at DX Separate metastatic nodules in contralateral lung Code 23 Direct extension to skeletal muscle, sternum, or skin of chest Code 37 Pop Quiz 4 cm right upper lobe lung mass, probably malignant; right and left pleural effusion per CT of chest. Liver metastasis per abdominal CT. What is the code for CS Mets at DX? 15: Ipsilateral malignant pleural effusion 16: Contralateral malignant pleural effusion 17: Ipsilateral & contralateral malignant pleural effusion 40: Abdominal organs; distant metastasis except distant lymph nodes 42: Distant metastasis plus pleural or pericardial effusion NAACCR 2011 2012 Webinar Series 26

SSF1: Separate Tumor Nodules Ipsilateral Lung Code Description 000 No separate tumor nodules noted 010 Separate tumor nodules in ipsilateral lung, same lobe 020 Separate tumor nodules in ipsilateral lung, different lobe 030 Separate tumor nodules, ipsilateral lung, same and different lobe 040 Separate tumor nodules, ipsilateral lung, unknown if same or different lobe 888 OBSOLETE 988 Not applicable 999 Unknown Question What is ground glass opacity? Does its presence on a CT scan with a measured malignant lesion of the lung indicate separate tumor nodules? Answer Ground glass opacity Refers to the presence of increased hazy opacity within the lungs that is not associated with obscured underlying vessels Can represent active disease such as pulmonary edema, pneumonia, or diffuse alveolar damage Do not count as other malignant nodules unless specified as such by the physician NAACCR 2011 2012 Webinar Series 27

Pop Quiz Patient is diagnosed with synchronous left lung tumors. Left upper lobe tumor contains bronchioloalveolar carcinoma; left lower lobe tumor contains squamous cell carcinoma. Using the MP/H rules, these are separate primaries. What is the code for SSF1 for the bronchioloalveolar carcinoma? 000: No separate tumor nodules 020: Separate tumor nodules in ipsilateral lung, different lobe 030: Separate tumor nodules, ipsilateral lung, same and different lobe 999: Unknown SSF2: Visceral Pleural Invasion (PL)/Elastic Layer Code Description 000 PL0: No evidence of visceral pleural invasion; Tumor does not completely traverse the elastic layer 010 PL1: Invasion beyond visceral pleura, but limited to pulmonary pleura; Tumor extends through elastic layer 020 PL2: Invasion to surface of pulmonary pleura; Tumor extends to surface of visceral pleura 030 PL3: Tumor extends to parietal pleura 040 Invasion of pleura, NOS 888 OBSOLETE 988 Not applicable 998 No histologic examination of pleura 999 Unknown Pop Quiz CT scan of chest: 4 cm tumor of right upper lung with direct invasion of the visceral pleura and mediastinal lymphadenopathy. Lung biopsy: poorly differentiated small cell carcinoma. Patient deemed inoperable. What is the code for SSF2? 020: PL 2 Tumor extends to surface of visceral pleura 040: Invasion of pleura NOS 998: No histologic examination of pleura 999: Unknown NAACCR 2011 2012 Webinar Series 28

Standard Setters SSF Requirements CS v02.03: Lung SSF1: Separate Tumor Nodules Ipsilateral Lung Required: CoC, NPCR, SEER, Canadian Council of Cancer Registries SSF2: Visceral Pleural Invasion (PL)/Elastic Layer Required: CoC, SEER Collect if in pathology report: Canadian Council of Cancer Registries Not required: NPCR Questions? QUIZ 2 Coming up! 3/1/12 Abstracting and Coding Boot Camp: Cancer Case Scenarios 4/5/12 Collecting Cancer Data: Lower Digestive System And the winners of the fabulous prizes are. 87 NAACCR 2011 2012 Webinar Series 29

Thank You! 88 NAACCR 2011 2012 Webinar Series 30